Litcius/Paper detail

Activation of the adipocyte CREB/CRTC pathway in obesity

Young‐Sil Yoon, Weiyi Liu, Sam Van de Velde, Shigenobu Matsumura, Ezra Wiater, Ling Huang, Marc Montminy

2021Communications Biology35 citationsDOIOpen Access PDF

Abstract

Obesity is a major risk factor for the development of type II diabetes. Increases in adipose tissue mass trigger insulin resistance via the release of pro-inflammatory cytokines from adipocytes and macrophages. CREB and the CRTC coactivators have been found to promote insulin resistance in obesity, although the mechanism is unclear. Here we show that high fat diet feeding activates the CREB/CRTC pathway in adipocytes by decreasing the expression of SIK2, a Ser/Thr kinase that phosphorylates and inhibits CRTCs. SIK2 levels are regulated by the adipogenic factor C/EBPα, whose expression is reduced in obesity. Exposure to PPARγ agonist rescues C/EBPα expression and restores SIK2 levels. CRTC2/3 promote insulin resistance via induction of the chemokines CXCL1/2. Knockout of CRTC2/3 in adipocytes reduces CXCL1/2 expression and improves insulin sensitivity. As administration of CXCL1/2 reverses salutary effects of CRTC2/3 depletion, our results demonstrate the importance of the CREB/CRTC pathway in modulating adipose tissue function.

Topics & Concepts

CREBEndocrinologyInternal medicineAdipocyteInsulin resistanceAdipose tissueAdipogenesisCXCL1ChemistryCell biologyInsulinTranscription factorBiologyMedicineChemokineReceptorBiochemistryGeneAdipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismMetabolism, Diabetes, and Cancer
Activation of the adipocyte CREB/CRTC pathway in obesity | Litcius